Literature DB >> 2575832

Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.

E C Hirsch1, A M Graybiel, Y Agid.   

Abstract

From a neuropathological point, the diagnosis of Parkinson's disease is confirmed by a neuronal cell loss and the presence of Lewy bodies in the substantia nigra. In Parkinson's disease, the precise type of nigral neuron which degenerate still remains unknown. Are all types of neuron similarly injured, are only subpopulations of neurons vulnerable? In an attempt to answer the question, a qualitative and quantitative analysis of the distribution of dopaminergic cells, as identified by immunohistochemistry with a specific antibody against tyrosine hydroxylase, was performed in the ventral mesencephalon of control subjects and patients who died with a clinical diagnosis of Parkinson's disease. In control brains, two types of catecholaminergic neurons were evidenced; some contain visible-neuromelanin, others do not. In patients with Parkinson's disease, the tyrosine hydroxylase positive cells which contained the pigment were the most vulnerable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575832     DOI: 10.1111/j.1600-0404.1989.tb01778.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  23 in total

Review 1.  Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease.

Authors:  Julie K Andersen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 2.  Progesterone receptors in mammary gland development and tumorigenesis.

Authors:  Orla M Conneely; Biserka M Jericevic; John P Lydon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

3.  Receptor alterations in manganese intoxicated monkeys.

Authors:  H Eriksson; P G Gillberg; S M Aquilonius; K G Hedström; E Heilbronn
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

4.  Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat.

Authors:  Michelle Healy-Stoffel; S Omar Ahmad; John A Stanford; Beth Levant
Journal:  Brain Res       Date:  2014-06-09       Impact factor: 3.252

5.  Inflaming the diseased brain: a role for tainted melanins.

Authors:  T M Jeitner; M Kalogiannis; P A Patrick; I Gomolin; T Palaia; L Ragolia; D Brand; E J Delikatny
Journal:  Biochim Biophys Acta       Date:  2015-01-10

6.  Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.

Authors:  Guoxiang Liu; Jia Yu; Jinhui Ding; Chengsong Xie; Lixin Sun; Iakov Rudenko; Wang Zheng; Namratha Sastry; Jing Luo; Gay Rudow; Juan C Troncoso; Huaibin Cai
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

Review 7.  Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.

Authors:  Rainer Knörle
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

8.  HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific.

Authors:  Douglas R Miller; Fatemeh Shaerzadeh; Leah Phan; Nesrin Sharif; Joyonna Gamble-George; Jay P McLaughlin; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  Glia       Date:  2018-05-07       Impact factor: 7.452

9.  Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

Authors:  Joshua M Milber; Joseph V Noorigian; James F Morley; Helen Petrovitch; Lon White; G Webster Ross; John E Duda
Journal:  Neurology       Date:  2012-11-14       Impact factor: 9.910

10.  Catecholamine neuron groups in rat brain slices differ in their susceptibility to excitatory amino acid induced dendritic degeneration.

Authors:  P T Bywood; S M Johnson
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.